Cancer research in the United States: A critical review of current status and proposal for alternative models-Reference-Cited by-同舟云学术

Cancer research in the United States: A critical review of current status and proposal for alternative models

Author:

Kantarjian Hagop M.¹^ORCID,Prat Ferran²,Steensma David P.³,Kurzrock Razelle⁴^ORCID,Stewart David J.⁵,Sekeres Mikkael A.⁶,Leveque Joseph⁷

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Research Administration and Industry Ventures; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Medical Oncology; Dana-Farber Cancer Institute, Harvard Medical School; Boston Massachusetts

4. Division of Hematology/Oncology, Department of Medicine; University of California at San Diego; San Diego California

5. Department of Medicine; University of Ottawa; Ottawa Ontario Canada

6. Leukemia Program, Cleveland Clinic; Cleveland Ohio

7. ARMO BioSciences; Redwood City California

Funder

Charif Souki Cancer Research Fund

University of Texas MD Anderson Cancer Center

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference85 articles.

1. National Cancer Institute History of the National Cancer Institute https://www.cancer.gov/about-nci/overview/history 2018

5. Quadruple combination therapy (VAMP) for acute lymphocytic leukemia of childhood;Freireich;Proc Am Assoc Cancer Res.,1964

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献